Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.630
+0.020 (1.24%)
At close: Aug 13, 2025, 4:00 PM
1.650
+0.020 (1.23%)
Pre-market: Aug 14, 2025, 9:17 AM EDT
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $110.46 million as of August 14, 2025. Its market cap has decreased by -80.54% in one year.
Market Cap
110.46M
Enterprise Value
-76.31M
1-Year Change
-80.54%
Ranking
Category
Stock Price
1.63
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $110.46M, a decrease of -72.61%. That is a compound annual growth rate of -27.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 110.46M | -8.72% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |